{
    "Trade/Device Name(s)": [
        "Lithium Assay for ADVIA IMS",
        "Assayed Chemistry Control 1",
        "Assayed Chemistry Control 2",
        "Chemistry Calibrator"
    ],
    "Submitter Information": "Bayer HealthCare LLC Diagnostics Division",
    "510(k) Number": "K050374",
    "Predicate Device Reference 510(k) Number(s)": [],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "NDW",
        "JIX",
        "JJY"
    ],
    "Summary Letter Date": "June 15, 2005",
    "Summary Letter Received Date": "May 25, 2005",
    "Submission Date": "May 23, 2005",
    "Regulation Number(s)": [
        "21 CFR 862.3560"
    ],
    "Regulation Name(s)": [
        "Lithium test system"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "tdm"
    ],
    "Analyte(s)": [
        "Lithium"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "ADVIA IMS",
        "ADVIA Chemistry",
        "Technicon RA",
        "opeRA systems"
    ],
    "Method(s)/Technology(ies)": [],
    "Methodologies": [],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control"
    ],
    "Document Summary": "FDA 510(k) summary for ADVIA IMS Lithium assay, calibrator, and controls for measurement of lithium in serum and plasma for bipolar disorder treatment monitoring",
    "Indications for Use Summary": "In vitro diagnostic device intended to measure lithium in human serum and plasma, used as an aid in monitoring lithium levels during bipolar disorder treatment",
    "fda_folder": "Toxicology"
}